Some 5‐acylaminoacylamino‐benzophenone derivatives were designed as bisubstrateanaloguefarnesyltransferaseinhibitors. These compounds turned out to be only weakly active against farnesyltransferase, but displayed an antiproliferative effect rendering them suitable for further development as a novel type of cytostatic agents.